Literature DB >> 21281801

Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.

Kyoungmin Park1, Ji Jin, Yang Hu, Kevin Zhou, Jian-xing Ma.   

Abstract

Pigment epithelium-derived factor (PEDF) is a serine proteinase inhibitor with antiangiogenic activities. To investigate whether PEDF overexpression has an impact on ocular neovascularization in vivo, we generated PEDF transgenic (PEDF-Tg) mice that ubiquitously express human PEDF driven by the β-actin promoter. The PEDF-Tg mice under normal conditions did not show any abnormalities in retinal histologic findings or visual function. In contrast, PEDF-Tg animals with oxygen-induced retinopathy (OIR) developed significantly less severe retinal neovascularization compared with wild-type (Wt) mice with OIR. In addition, PEDF-Tg mice with OIR had significantly lower vascular leakage in the retina but higher occludin levels than the Wt mice with OIR, suggesting a protective effect on the blood-retinal barrier. Furthermore, retinal levels of proinflammatory factors were significantly lower in PEDF-Tg mice with OIR than in the Wt mice with OIR. In the laser-induced choroidal neovascularization (CNV) model, the CNV area was significantly smaller in the PEDF-Tg mice than in the Wt mice. Also, the laser burn-induced overexpression of proangiogenic and inflammatory factors was observed in the retina and retinal pigment epithelium of Wt mice but not in PEDF-Tg mice. Taken together, these results suggest that overexpression of PEDF inhibits retinal inflammation and neovascularization in both the OIR and laser-induced CNV models. The PEDF-Tg mice provide a useful model for studying the roles of angiogenic inhibitors in neovascular disorders such as diabetic retinopathy.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281801      PMCID: PMC3070578          DOI: 10.1016/j.ajpath.2010.10.014

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  69 in total

1.  Angiogenic pathways in diabetic retinopathy.

Authors:  Lloyd Paul Aiello
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

2.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

3.  Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1.

Authors:  Jun Cai; Wen G Jiang; Maria B Grant; Mike Boulton
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

4.  Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy.

Authors:  Søren T Knudsen; Toke Bek; Per L Poulsen; Marianne N Hove; Michael Rehling; Carl E Mogensen
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

5.  Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice.

Authors:  R S Clements; W G Robison; M P Cohen
Journal:  J Diabetes Complications       Date:  1998 Jan-Feb       Impact factor: 2.852

6.  Dual role of intravitreous infliximab in experimental choroidal neovascularization: effect on the expression of sulfated glycosaminoglycans.

Authors:  Caio V Regatieri; Juliana L Dreyfuss; Gustavo B Melo; Daniel Lavinsky; Michel E Farah; Helena B Nader
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-10       Impact factor: 4.799

7.  Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family.

Authors:  F R Steele; G J Chader; L V Johnson; J Tombran-Tink
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

8.  Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.

Authors:  Ying Chen; Yang Hu; Ti Zhou; Kevin K Zhou; Robert Mott; Mingyuan Wu; Michael Boulton; Timothy J Lyons; Guoquan Gao; Jian-xing Ma
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

Review 9.  Diabetic macular edema: review and update.

Authors:  Christopher Pelzek; Jennifer I Lim
Journal:  Ophthalmol Clin North Am       Date:  2002-12

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  43 in total

Review 1.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

2.  Pigment epithelium-derived factor (PEDF) suppresses IL-1β-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling.

Authors:  Arijeet K Gattu; Andreas L Birkenfeld; Yasuko Iwakiri; Steven Jay; Mark Saltzman; Jennifer Doll; Petr Protiva; Varman T Samuel; Susan E Crawford; Chuhan Chung
Journal:  Endocrinology       Date:  2014-01-23       Impact factor: 4.736

3.  Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.

Authors:  Alicia J Jenkins; Dongxu Fu; Madona Azar; Julie A Stoner; Derrick G Kaufman; Sarah Zhang; Richard L Klein; Maria F Lopes-Virella; Jian-Xing Ma; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2014-01-17       Impact factor: 2.852

4.  Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.

Authors:  Ahmed S Ibrahim; Amany M Tawfik; Khaled A Hussein; Sally Elshafey; Shanu Markand; Nasser Rizk; Elia J Duh; Sylvia B Smith; Mohamed Al-Shabrawey
Journal:  Biochim Biophys Acta       Date:  2015-01-03

5.  Inhibition of choroidal neovascularization by lentivirus-mediated PEDF gene transfer in rats.

Authors:  Ya-Jie Yu; Bin Mo; Lu Liu; Yan-Kun Yue; Chang-Li Yue; Wu Liu
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

Review 6.  Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy.

Authors:  Changyow C Kwan; Amani A Fawzi
Journal:  Curr Diab Rep       Date:  2019-08-31       Impact factor: 4.810

Review 7.  Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.

Authors:  Elizabeth P Moran; Zhongxiao Wang; Jing Chen; Przemyslaw Sapieha; Lois E H Smith; Jian-Xing Ma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-29       Impact factor: 4.733

8.  γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines.

Authors:  Xiaoping Qi; Jun Cai; Qing Ruan; Li Liu; Sanford L Boye; Zhijuan Chen; William W Hauswirth; Renee C Ryals; Lynn Shaw; Sergio Caballero; Maria B Grant; Michael E Boulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

9.  Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy.

Authors:  Nader Sheibani; Ismail S Zaitoun; Shoujian Wang; Soesiawati R Darjatmoko; Andrew Suscha; Yong-Seok Song; Christine M Sorenson; Victor Shifrin; Daniel M Albert; Ignacio Melgar-Asensio; Irawati Kandela; Jack Henkin
Journal:  Exp Eye Res       Date:  2020-04-06       Impact factor: 3.467

10.  Positive correlation between PEDF expression levels and macrophage density in the human prostate.

Authors:  Thomas Nelius; Christina Samathanam; Dalia Martinez-Marin; Natalie Gaines; Jessica Stevens; Johnny Hickson; Werner de Riese; Stéphanie Filleur
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.